Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5602259 | European Journal of Vascular and Endovascular Surgery | 2017 | 15 Pages |
Abstract
Dual antiplatelet therapy demonstrates advantages over single therapy only in CAS, as indicated by a reduced risk of TIA. Dual antiplatelet therapy was associated with an increased risk of bleeding complications in patients undergoing CEA.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
M. Barkat, S. Hajibandeh, S. Hajibandeh, F. Torella, G.A. Antoniou,